2 Global Human Liver Model Quarterly Market Size Analysis

• 2.1 Human Liver Model Business Impact Assessment - COVID-19
  • 2.1.1 Global Human Liver Model Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Human Liver Model Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Human Liver Model Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Human Liver Model Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Human Liver Model Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Human Liver Model Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Human Liver Model Market
• 3.5 Key Manufacturers Human Liver Model Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Human Liver Model Segments, By Type

• 4.1 Introduction
  • 1.4.1 Liver Organoids
  • 1.4.2 Liver-on-a-chip
  • 1.4.3 2D Models
  • 1.4.4 3D Bioprinting
  • 1.4.5 Others
• 4.2 By Type, Global Human Liver Model Market Size, 2019-2021
  • 4.2.1 By Type, Global Human Liver Model Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Human Liver Model Price, 2020-2021

5 Impact of Covid-19 on Human Liver Model Segments, By Application

• 5.1 Overview
  • 5.5.1 Drug Discovery
  • 5.5.2 Education
  • 5.5.3 Others
• 5.2 By Application, Global Human Liver Model Market Size, 2019-2021
  • 5.2.1 By Application, Global Human Liver Model Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Human Liver Model Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Emulate (US)
  • 7.1.1 Emulate (US) Business Overview
  • 7.1.2 Emulate (US) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.1.3 Emulate (US) Human Liver Model Product Introduction
  • 7.1.4 Emulate (US) Response to COVID-19 and Related Developments
• 7.2 Ascendance Bio (US)
  • 7.2.1 Ascendance Bio (US) Business Overview
  • 7.2.2 Ascendance Bio (US) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.2.3 Ascendance Bio (US) Human Liver Model Product Introduction
  • 7.2.4 Ascendance Bio (US) Response to COVID-19 and Related Developments
• 7.3 HIREL (US)
  • 7.3.1 HIREL (US) Business Overview
  • 7.3.2 HIREL (US) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.3.3 HIREL (US) Human Liver Model Product Introduction
  • 7.3.4 HIREL (US) Response to COVID-19 and Related Developments
• 7.4 CN Bio (UK)
  • 7.4.1 CN Bio (UK) Business Overview
  • 7.4.2 CN Bio (UK) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.4.3 CN Bio (UK) Human Liver Model Product Introduction
  • 7.4.4 CN Bio (UK) Response to COVID-19 and Related Developments
• 7.5 Organovo (US)
  • 7.5.1 Organovo (US) Business Overview
  • 7.5.2 Organovo (US) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.5.3 Organovo (US) Human Liver Model Product Introduction
  • 7.5.4 Organovo (US) Response to COVID-19 and Related Developments
• 7.6 Cyfuse Biomedical (Japan)
  • 7.6.1 Cyfuse Biomedical (Japan) Business Overview
  • 7.6.2 Cyfuse Biomedical (Japan) Human Liver Model Quarterly Production and Revenue, 2020
  • 7.6.3 Cyfuse Biomedical (Japan) Human Liver Model Product Introduction
  • 7.6.4 Cyfuse Biomedical (Japan) Response to COVID-19 and Related Developments
• 7.7 Mimetas
  • 7.7.1 Mimetas Business Overview
  • 7.7.2 Mimetas Human Liver Model Quarterly Production and Revenue, 2020
  • 7.7.3 Mimetas Human Liver Model Product Introduction
  • 7.7.4 Mimetas Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Human Liver Model Supply Chain Analysis
  • 8.1.1 Human Liver Model Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Human Liver Model Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Human Liver Model Distribution Channels
  • 8.2.2 Covid-19 Impact on Human Liver Model Distribution Channels
  • 8.2.3 Human Liver Model Distributors
• 8.3 Human Liver Model Customers

9 Key Findings

10 Appendix

• 10.1 About Us

This report covers market size and forecasts of Human Liver Model, including the following market information:
Global Human Liver Model Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Human Liver Model Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Human Liver Model Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Human Liver Model Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players
Major competitors identified in this market include Emulate (US), Ascendance Bio (US), HIREL (US), CN Bio (UK), Organovo (US), Cyfuse Biomedical (Japan), Mimetas, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Liver Organoids
Liver-on-a-chip
2D Models
3D Bioprinting
Others

Based on the Application:
Drug Discovery
Education
Others